The mucopolysaccharidosis treatment market is growing due to rising awareness of rare genetic disorders, expanded use of enzyme replacement therapies, and emerging gene therapy candidates targeting subtypes of MPS. https://www.datamintelligence.com/research-report/mucopolysaccharidosis-treatment-market